Full-Time

Senior Scientist

PK & Biomarker

Posted on 8/6/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Laval, QC, Canada

In Person

Category
Biology & Biotech (2)
,
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • Ideally College degree and/or University degree in Chemistry, Biochemistry, Immunology or applicable field.
  • Experience in developing immunological methods, ideally ELISA/ECLIA.
  • Knowledge of regulatory agency guidelines; must deeply understand general SOPs and have an excellent knowledge of GCP/GLP regulations.
  • Minimum of 2 years experience as Scientist II or equivalent.
  • Good organizational skill, highly flexible, sense of urgency, excellent troubleshooting skills.
  • Able to easily read and understand study plans and protocols and ability to coach/mentor people.
  • Client oriented, attentive to details.
  • Strong communication both written and verbal in French & English.
Responsibilities
  • Could be assigned to assay development, qualification, validation and production expert in multiple assay types and mentor for more junior staff.
  • Autonomous and proficient developing, planning, managing, conducting, reporting and troubleshooting multiple assay types to ensure scientific quality, regulatory expectations, and client satisfaction.
  • Assigned by management on studies and tasks based on scientific competency and training (can include method development, validation or sample analysis projects).
  • For validations and sample analysis the Scientist can be assigned as Bioanalytical Principal Investigator and is the first point of contact for PM and/or clients for laboratory services and will manage and conduct method development, qualification, validation and production studies for clinical and non-clinical studies in compliance with the protocol/study plan, amendments, GCP, GLPs, SOPs and Best Practices;
  • Manage project and order appropriate material, as needed.
  • When applicable, provide QC support on studies assigned to other team members in laboratory based on training and competencies. When applicable, perform data batch review, perform multi-batch trend analysis, complete documentation as required by tracking deviations, events and reports of non-compliance and review or approved Memo to File or SOP/Protocol/Study Plan deviations; When applicable, provide a report and/or reporting of results, within study timelines and ensure any deviations/exception events are reflected as appropriate and assure that all analysis conducted is reported and is accurate;
  • Manage as to maintain timeline and scheduling commitments.
  • When applicable review and provide comments and recommendations, as needed, for the bioanalytical portions of preclinical and clinical protocols, study plans, laboratory manuals, Data Transfer Agreements, and/or other document, as needed;
  • Support and mentor Analysts in the daily operations for completion of sample analysis and/or validation studies and the analysts work;
  • Support and mentor other team members based on expertise,
  • Responsible for troubleshooting issues within the studies and be able to resolve them independently via development of appropriate procedure.
  • Organize and communicate complex data sets in a clear and concise manner to key stakeholders from diverse backgrounds.
  • To write, review and updated method SOP as needed.
  • Participate in meetings with clients, conferences and scientific outreach.
  • Conduct applicable work in compliance with applicable SOPs, GCPs, GLPs, and observe all company guidelines and policies.
  • Respecting Health and Safety standards in terms of personal protection, laboratory maintenance, and work procedures.
Desired Qualifications
  • Preferred experience in regulated clinical and/or preclinical studies with typically 3 years of experience.
  • It is of added value if the candidate also has experience in developing multiplex assays for biomarkers on ECLIA and/or luminex.
  • It is of added value if the candidate has experience in working with various tissue matrices or biopsies.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE